Latest | F'cast | |
---|---|---|
Div Yield | 4.0% | 0.0% |
Div Cover | 1.1 | 1.1 |
Op Mrgn | 16.7% | 20.3% |
ROCE | 31.9% |
Latest | F'cast | |
---|---|---|
P/E | 22.2 | 20.5 |
PEG | 0.5 | 4.8 |
Pr/Revenue | 3.9 | 3.4 |
Pr/Book | 5.0 |
Latest | F'cast | |
---|---|---|
Revenue | 16.5% | 10.3% |
PBT | 38.5% | 32.3% |
EPS | 43.8% | 4.3% |
DPS | 28.8% | 7.7% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 31.68 | 6.64 | 12.35p | 34.4 | 2.9 | +12% | 6.18p | 1.5% |
30-Jun-21 | 31.00 | 3.76 | 11.36p | 56.2 | n/a | -8% | 6.55p | 1.0% |
30-Jun-22 | 31.12 | 1.50 | 8.40p | 42.0 | n/a | -26% | 6.55p | 1.9% |
30-Jun-23 | 36.01 | 5.11 | 10.67p | 33.3 | 1.2 | +27% | 10.50p | 3.0% |
30-Jun-24 | 41.93 | 7.08 | 15.34p | 29.8 | 0.7 | +44% | 13.52p | 3.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-25 | 46.27 | 9.37 | 16.00p | 21.2 | 4.9 | +4% | 14.56p | 0.0% |
30-Jun-26 | 51.16 | 11.04 | 17.98p | 18.9 | 1.5 | +12% | 15.71p | 0.0% |
30-Jun-27 | 56.66 | 13.54 | 21.46p | 15.8 | 0.8 | +19% | 16.40p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Additional info. submitted to FDA for Tristel OPH | 10-Apr-2025 | 07:00 | RNS |
Publication of Poster by Mayo Clinic & US update | 09-Apr-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 02-Apr-2025 | 07:00 | RNS |
Cash planted into TEG | 11-Nov-2007 | Scotland on Sunday |
Space at a premium | 05-Nov-2006 | Scotland on Sunday |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
26-Mar-25 | Buy | Matthew (Matt) Giovanni Sassone | 310.00p | 3,500 | £10,850.00 |
Currency | UK Pounds |
Share Price | 342.50p |
Change Today | 2.50p |
% Change | 0.74 % |
52 Week High | 500.00 |
52 Week Low | 270.00 |
Volume | 108,534 |
Shares Issued | 47.70m |
Market Cap | £163.38m |
RiskGrade | 180 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 20-Mar-25 | 28-Nov-24 |
Paid | 11-Apr-25 | 20-Dec-24 |
Amount | 5.68p | 8.28p |
Time | Volume / Share Price |
15:31 | 500 @ 343.60p |
15:31 | 100 @ 340.00p |
15:11 | 2,000 @ 343.55p |
14:39 | 4 @ 348.90p |
14:11 | 107 @ 348.90p |
Finance Director | Elizabeth Dixon |
CEO | Matthew (Matt) Giovanni Sassone |
You are here: research